233 related articles for article (PubMed ID: 10481106)
21. Correlation of neuropsychological evaluation and SPECT imaging in patients with Alzheimer's disease.
Lampl Y; Sadeh M; Laker O; Lorberboym M
Int J Geriatr Psychiatry; 2003 Apr; 18(4):288-91. PubMed ID: 12673603
[TBL] [Abstract][Full Text] [Related]
22. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: a SPECT study using HMPAO and image standardization technique.
Imran MB; Kawashima R; Awata S; Sato K; Kinomura S; Ono S; Yoshioka S; Sato M; Fukuda H
J Nucl Med; 1999 Feb; 40(2):244-9. PubMed ID: 10025830
[TBL] [Abstract][Full Text] [Related]
23. Basal and activational 99Tcm-HMPAO brain SPECT in Alzheimer's disease.
Sayit E; Yener G; Capa G; Ertay T; Keskin B; Fadiloglu S; Durak H
Nucl Med Commun; 2000 Aug; 21(8):763-8. PubMed ID: 11039460
[TBL] [Abstract][Full Text] [Related]
24. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
van Dyck CH; Lin CH; Smith EO; Wisniewski G; Cellar J; Robinson R; Narayan M; Bennett A; Delaney RC; Bronen RA; Hoffer PB
J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168
[TBL] [Abstract][Full Text] [Related]
25. Combined magnetic resonance imaging and single-photon emission tomography scanning in the discrimination of Alzheimer's disease from age-matched controls.
O'Brien JT; Ames D; Desmond P; Lichtenstein M; Binns D; Schweitzer I; Davis S; Tress B
Int Psychogeriatr; 2001 Jun; 13(2):149-61. PubMed ID: 11495391
[TBL] [Abstract][Full Text] [Related]
26. Regional cerebral blood flow single-photon emission tomography with 99mTc-HMPAO and the acetazolamide test in the evaluation of vascular and Alzheimer's dementia.
Pávics L; Grünwald F; Reichmann K; Horn R; Kitschenberg A; Hartmann A; Menzel C; Schomburg AG; Overbeck B; Csernay L; Biersack HJ
Eur J Nucl Med; 1999 Mar; 26(3):239-45. PubMed ID: 10079314
[TBL] [Abstract][Full Text] [Related]
27. The value of HMPAO SPECT scanning in the diagnosis of early Alzheimer's disease in patients attending a memory clinic.
McMurdo ME; Grant DJ; Kennedy NS; Gilchrist J; Findlay D; McLennan JM
Nucl Med Commun; 1994 Jun; 15(6):405-9. PubMed ID: 8078635
[TBL] [Abstract][Full Text] [Related]
28. Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance.
Giovagnoli AR; Erbetta A; Reati F; Bugiani O
Neuropsychologia; 2008 Apr; 46(5):1495-504. PubMed ID: 18262206
[TBL] [Abstract][Full Text] [Related]
29. Clinical-physiologic correlates of Alzheimer's disease and frontal lobe dementia.
Jagust WJ; Reed BR; Seab JP; Kramer JH; Budinger TF
Am J Physiol Imaging; 1989; 4(3):89-96. PubMed ID: 2789844
[TBL] [Abstract][Full Text] [Related]
30. The investigation of Alzheimer's disease with single photon emission tomography.
Burns A; Philpot MP; Costa DC; Ell PJ; Levy R
J Neurol Neurosurg Psychiatry; 1989 Feb; 52(2):248-53. PubMed ID: 2467967
[TBL] [Abstract][Full Text] [Related]
31. The discriminant value of semiquantitative SPECT data in mild Alzheimer's disease.
O'Mahony D; Coffey J; Murphy J; O'Hare N; Hamilton D; Freyne P; Walsh JB; Coakley D
J Nucl Med; 1994 Sep; 35(9):1450-5. PubMed ID: 8071690
[TBL] [Abstract][Full Text] [Related]
32. The reversed clock drawing test phenomenon in Alzheimer's disease: A perfusion SPECT study.
Brugnolo A; Morbelli S; Dessi B; Girtler N; Mazzei D; Famà F; Barbieri P; Cabassi G; Koulibaly PM; Sambuceti G; Rodriguez G; Nobili F
Dement Geriatr Cogn Disord; 2010; 29(1):1-10. PubMed ID: 20093833
[TBL] [Abstract][Full Text] [Related]
33. Tc-99m HMPAO brain SPECT findings in mild and moderate Alzheimer's disease: correlation with event related potentials.
Gungor HA; Yildiz A; Aydin F; Gungor F; Boz A; Ozkaynak S
J Neurol Sci; 2005 Jul; 234(1-2):47-53. PubMed ID: 15950243
[TBL] [Abstract][Full Text] [Related]
34. The role of PET/CT amyloid Imaging compared with Tc99m-HMPAO SPECT imaging for diagnosing Alzheimer's disease.
Suppiah S; Ching SM; Nordin AJ; Vinjamuri S
Med J Malaysia; 2018 Jun; 73(3):141-146. PubMed ID: 29962497
[TBL] [Abstract][Full Text] [Related]
35. Statistical parametric mapping of brain SPECT perfusion abnormalities in patients with Alzheimer's disease.
Lee YC; Liu RS; Liao YC; Sun CM; Wang PS; Wang PN; Liu HC
Eur Neurol; 2003; 49(3):142-5. PubMed ID: 12646756
[TBL] [Abstract][Full Text] [Related]
36. [Detection of early cases of Alzheimer's disease. Application of the CERAD neuropsychological test battery].
Larumbe R
Rev Med Univ Navarra; 1997; 41(1):6-11. PubMed ID: 9527716
[TBL] [Abstract][Full Text] [Related]
37. Alzheimer's disease and frontotemporal dementia are differentiated by discriminant analysis applied to (99m)Tc HmPAO SPECT data.
Charpentier P; Lavenu I; Defebvre L; Duhamel A; Lecouffe P; Pasquier F; Steinling M
J Neurol Neurosurg Psychiatry; 2000 Nov; 69(5):661-3. PubMed ID: 11032624
[TBL] [Abstract][Full Text] [Related]
38. The diagnosis of Alzheimer's disease: a question of image?
Jobst KA; Hindley NJ; King E; Smith AD
J Clin Psychiatry; 1994 Nov; 55 Suppl():22-31. PubMed ID: 7989291
[TBL] [Abstract][Full Text] [Related]
39. Correlation between neuropsychological tests and hypoperfusion in MCI patients: anatomical labeling using xjView and Talairach Daemon software.
Yoon HJ; Park KW; Jeong YJ; Kang DY
Ann Nucl Med; 2012 Oct; 26(8):656-64. PubMed ID: 22777857
[TBL] [Abstract][Full Text] [Related]
40. Correlations between SPECT regional cerebral blood flow and psychometric testing in patients with Alzheimer's disease.
Sabbagh MN; Lynn P; Jhingran S; Massman P; Villanueva-Meyer J; Olup J; Doody RS
J Neuropsychiatry Clin Neurosci; 1997; 9(1):68-74. PubMed ID: 9017531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
